Patient risk profiles for progression of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

European Urology, Supplements

Volumn 3, Issue 4, 2004, Pages 7-11

  Lowe, Franklin C ^a  

^a 425 W ^*  (United States)

Author keywords

Acute urinary retention; Benign prostatic hyperplasia; Disease progression; Lower urinary tract symptoms; Risk factors; Surgery

Indexed keywords

FINASTERIDE;

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; HUMAN; MEDICAL SPECIALIST; POPULATION; PREDICTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUESTIONNAIRE; REVIEW; RISK FACTOR; URINARY TRACT DISEASE;

EID: 4544294002     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2004.08.002     Document Type: Article

References (17)

1. W. Artibani Integrating the patient risk profile in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) Eur Urol Suppl 3 4 2004 1 6
2. F. Jimenez-Cruz Identifying patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) at risk for progression Eur Urol Suppl 2 7 2003 6 12
3. S.J. Jacobsen, D.J. Jacobson, C.J. Girman, R.O. Roberts, T. Rhodes, and H.A. Guess Natural history of prostatism: risk factors for acute urinary retention J Urol. 158 1997 481 487
4. J.B. Meigs, M.J. Barry, E. Giovannucci, E.B. Rimm, M.J. Stampfer, and I. Kawachi Incidence rates and risk factors for acute urinary retention: the health professionals followup study J Urol 162 1999 376 382
5. M.M. Lieber, D.J. Jacobsen, C.J. Girman, R.O. Roberts, T. Rhodes, and S.J. Jabobsen Incidence of lower urinary tract symptom progression in community-dwelling men: 9-year follow-up of the Olmsted County study of urinary symptoms and health status among men J Urol. 169 Suppl 2003 366 [Abstract 1369]
6. S.J. Jacobsen, D.J. Jacobsen, C.J. Girman, R.O. Roberts, T. Rhodes, and M.M. Lieber Acute urinary retention in community-dwelling men: 9-year follow-up of the Olmsted County study of urinary symptoms and health status among men J Urol 169 Suppl 2003 365 [Abstract 1364]
7. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Dixon CM, Kusek JW, et al., for the Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387-98.
8. J.D. McConnell, R. Bruskewitz, P. Walsh, G. Andriole, M. Lieber, H.L. Holtgrewe for the Finasteride Long-Term Efficacy and Safety Study Group The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia N Engl J Med. 338 1998 557 563
9. C.G. Roehrborn, J.D. McConnell, M.M. Lieber, S.A. Kaplan, J. Geller, G.H. Malek for the PLESS Study Group Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia Urology 53 1999 473 480
10. C.G. Roehrborn, J.D. McConnell, B. Saltzman, D. Bergner, T. Gray, P. Narayan for the PLESS Study Group Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes Eur Urol. 42 2002 1 6
11. M.J. Marberger, J.T. Andersen, J.C. Nickel, M.P. Malice, M. Gabriel, and F. Pappas Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials Eur Urol. 38 2000 563 568
12. J.D. McConnell, C.G. Roehrborn, K.M. Slawin, M.M. Lieber, J.A. Smtich, and S.A. Kaplan Baseline measures predict the risk of benign prostatic hyperplasia clinical progression in placebo-treated patients J Urol. 169 Suppl 2003 332 [Abstract 1287]
13. B. Djavan, J.C. Nickel, J. de la Rosette, and P. Abrams The urologist view of BPH progression: results of an international survey Eur Urol. 41 2002 490 496
14. T. McNicholas LUTS, the case is altered Eur Urol Suppl 1 9 2002 28 35
15. Web-based survey LUTS/BPH at Ismar Healthcare website (May-June 2003)
16. R.H. Brook, M.R. Chassin, A. Fink, D.H. Solomon, J. Kosecoff, and R.E. Park A method for the detailed assessment of the appropriateness of medical technologies Int J Technol Assess Health Care 2 1986 53 63
17. F. Lowe, J. Batista, E. Chartier Kastler, G. Conti, K. Dreikorn, and M. O'Leary Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia; a systematic analysis of expert opinion Eur Urol Suppl 3 2 2004 39 [Abstract 147]